Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

7.460
+0.1301.77%
Volume:500.00
Turnover:3.73K
Market Cap:6.08B
PE:-32.97
High:7.460
Open:7.460
Low:7.460
Close:7.330
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:- -
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.226
ROE:-4.26%
ROA:-2.48%
PB:1.46
PE(LYR):-32.97
PS:6.68

Loading ...

XTALPI Shares Surge Over 4% as First Annual Profit in 2025 Highlights Value of Unique AI Drug Platform

Stock News
·
Mar 16

China's CCTV 3.15 Gala Highlights Jinshan Pharmaceutical, Controller Xia Yong Serves as Vice President of Sichuan Entrepreneurs Association

Deep News
·
Mar 15

Military Procurement Implements Routine "Piercing" Sanctions: Qilu Pharmaceutical Banned, Compliance Risks for Drug Firms Escalate to Group Level

Deep News
·
Mar 12

Investors Prevail in Compensation Claim Against Hainan Poly Pharm. Despite Delisting

Deep News
·
Mar 12

Ocumension Therapeutics board to review annual results and consider final dividend

Reuters
·
Mar 10

Compensation Analysis of Eight Global Pharmaceutical CEOs in 2025

Deep News
·
Mar 10

ASCLETIS-B's Long-Acting GLP-1 Candidate Shows Promising Weight Loss in U.S. Phase II Trial

Stock News
·
Mar 10

Deepening Integration of Hunan and Hainan Strengths to Access Broader Global Markets, Says NPC Deputy Tang Yue

Deep News
·
Mar 10

Analyst Optimism Drives Surge in Cenotron Pharma Shares

Deep News
·
Mar 10

Guotai Haitong: AI-Driven Drug Development Advances with Accelerated MNC Adoption

Stock News
·
Mar 09

Zealand Pharma Stock Plummets 35% on Disappointing Drug Trial Results

Deep News
·
Mar 07

Hanfang Pharmaceutical's IPO: Flagship Product Peaks, New Drugs Offer No Quick Fix; Brothers with 100% Control Issue Large Dividends Before Listing

Deep News
·
Mar 06

Hanfang Pharmaceutical's IPO: Over-reliance on Single Product and Marketing-heavy Strategy Raise Concerns

Deep News
·
Mar 05

Ocumension-B (01477) Announces Monthly Return for Equity Issuer as of 28 February 2026

Bulletin Express
·
Mar 05

Investors Prevail in First-Round Lawsuit Against Puli Pharmaceutical, Additional Claims Welcome

Deep News
·
Mar 03

Pharmaceutical Patent Dispute Escalates to Supreme Court

Deep News
·
Mar 02

IPO Preview: Hanfang Pharmaceutical Faces Growth Test as Single Product Generates 90% of Revenue

Stock News
·
Feb 28

Revised title

Stock News
·
Feb 25

Pharmaceutical Supply Chain Momentum Strengthens: Sinolink Securities Highlights Dual Investment Themes in CXO Sector

Stock News
·
Feb 22

Madrigal Pharmaceuticals Enters Global Licensing Agreement with Suzhou Ribo for Liver Disease Programs

Deep News
·
Feb 11